Mizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech
Quick Read Merck’s Keytruda posted $8 billion in Q1 sales, while Summit’s ivonescimab faces binary risk ahead of…
Browsing Tag
Jared Holz
1 post